埃塞俄比亚的自我治疗实践:一个综合审查协议
Getahun Fetensa1,2,3, Eshetu Ejeta4, Tariku Tesfaye Bekuma5,6
1Department of Health Behavior and Society, Faculty of Public Health, Institute of Health, Jimma Medical Center, Jimma University, Jimma, Ethiopia.
PloS one
|February 27, 2025
概括
本综述考察了埃塞俄比亚的自我治疗实践,强调了其对健康和经济的影响. 调查结果将为应对抗微生物药物耐药性和改善公共卫生的干预提供信息.
科学领域:
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
- 系统审查方法论 系统审查方法论
背景情况:
- 自我治疗,即在没有专业指导的情况下使用药物,会给健康和经济带来重大风险.
- 这是一个普遍存在的问题,有可能加剧公共卫生挑战.
研究的目的:
- 系统地审查和综合现有证据,以埃塞俄比亚成年人自我治疗的做法.
- 识别与自我治疗相关的模式和因素,以告知有针对性的干预措施.
主要方法:
- 采用了一种综合性审查方法,重点关注系统性审查.
- 在 MEDLINE,Embase 和 Cochrane 系统审查数据库中进行了搜索.
- 数据提取和质量评估由两名独立审查员使用JBI批判性评估清单进行.
主要成果:
- 该审查将综合各种埃塞俄比亚人口的自我治疗实践数据.
- 提取的数据将包括研究特征,患者人口统计数据和报告的自我治疗行为.
- 将评估所包含的系统审查的质量,以确保调查结果的可靠性.
结论:
- 综合证据旨在提供对埃塞俄比亚自我治疗的全面了解.
- 结果将指导开发干预措施以减轻风险,特别是关于抗菌素耐药性的风险.
- 审查强调了在资源有限的环境中需要政府和非政府组织采取行动.
相关概念视频
Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drugs for Treatment of Diarrhea-Predominant IBS
139
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
139


